Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J G Brooks

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Vaccine|March 10, 2005
A strategic vaccine facility for the UKJacqueline M Duggan, Timothy J G Brooks
FEMS Immunology and Medical Microbiology|February 24, 2007
Structural modification of a base disaccharide alters antiadhesion properties towards Yersinia pestisRichard J Thomas, Andrew Hacking, Timothy J G Brooks
Journal of Travel Medicine|January 28, 2023
Infections in travellers returning to the UK: a retrospective analysis (2015-2020)Jennifer C Warner, Diane Hatziioanou, Jane C Osborne, et al.
International Journal of Antimicrobial Agents|May 14, 2010
Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis for experimental murine melioidosisDermot J Kenny, Armine M Sefton, Timothy J G Brooks, et al.
Emerging Infectious Diseases|December 21, 2016
Presence and Persistence of Zika Virus RNA in Semen, United Kingdom, 2016Barry Atkinson, Fiona Thorburn, Christina Petridou, et al.
The Journal of Infection|March 22, 2023
Imported rickettsial infections to the United Kingdom, 2015-2020Clare E Warrell, Jane Osborne, Laura Nabarro, et al.
International Journal of Antimicrobial Agents|December 22, 2009
Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infectionHelen S Atkins, Stephen Spencer, Simon D Brew, et al.
International Journal of Antimicrobial Agents|August 18, 2009
Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infectionHelen S Atkins, Stephen Spencer, Simon D Brew, et al.
The Journal of Infection|March 26, 2021
Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workersRoss J Harris, Heather J Whitaker, Nick J Andrews, et al.
Plos Medicine|April 20, 2016
Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical TrialJake Dunning, Foday Sahr, Amanda Rojek, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Vaccine|March 10, 2005
A strategic vaccine facility for the UKJacqueline M Duggan, Timothy J G Brooks
FEMS Immunology and Medical Microbiology|February 24, 2007
Structural modification of a base disaccharide alters antiadhesion properties towards Yersinia pestisRichard J Thomas, Andrew Hacking, Timothy J G Brooks
Journal of Travel Medicine|January 28, 2023
Infections in travellers returning to the UK: a retrospective analysis (2015-2020)Jennifer C Warner, Diane Hatziioanou, Jane C Osborne, et al.
International Journal of Antimicrobial Agents|May 14, 2010
Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis for experimental murine melioidosisDermot J Kenny, Armine M Sefton, Timothy J G Brooks, et al.
Emerging Infectious Diseases|December 21, 2016
Presence and Persistence of Zika Virus RNA in Semen, United Kingdom, 2016Barry Atkinson, Fiona Thorburn, Christina Petridou, et al.
The Journal of Infection|March 22, 2023
Imported rickettsial infections to the United Kingdom, 2015-2020Clare E Warrell, Jane Osborne, Laura Nabarro, et al.
International Journal of Antimicrobial Agents|December 22, 2009
Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infectionHelen S Atkins, Stephen Spencer, Simon D Brew, et al.
International Journal of Antimicrobial Agents|August 18, 2009
Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infectionHelen S Atkins, Stephen Spencer, Simon D Brew, et al.
The Journal of Infection|March 26, 2021
Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workersRoss J Harris, Heather J Whitaker, Nick J Andrews, et al.
Plos Medicine|April 20, 2016
Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical TrialJake Dunning, Foday Sahr, Amanda Rojek, et al.
Pageof 2